DDT \[2,2-bis(*p*-chlorophenyl)-1,1,1-trichloroethane\] is an organochlorine pesticide that was widely used in the 1950s and 1960s but is now restricted from use in the United States because of its persistence in the environment and effects on wildlife. 1,1-Dichloro-2,2-bis(*p*-chlorophenyl)ethylene (*p*,*p*′-DDE) is a particularly long-lasting, lipophilic breakdown product of DDT. Immunosuppressive effects, including reduction in immunoglobulin levels and decreased response to bacterial challenges, have been demonstrated in experimental studies of dietary DDT exposure in mice and rats ([@b3-ehp0112-001080], [@b4-ehp0112-001080]; [@b5-ehp0112-001080]; [@b10-ehp0112-001080]; [@b27-ehp0112-001080]). Laboratory and clinical studies have demonstrated the dual potential for immune suppression and dysregulation (e.g., autoantibody production) in response to chemical exposures, including the organochlorine hexachlorobenzene ([@b19-ehp0112-001080]; [@b24-ehp0112-001080]; [@b30-ehp0112-001080]) and mercury ([@b2-ehp0112-001080]; [@b26-ehp0112-001080]; [@b35-ehp0112-001080]). There are relatively few data pertaining to immunologic effects of DDT or DDE exposure in humans, and no studies have examined antinuclear antibodies in relation to biologic measures of exposure.

Currently in the United States, *p*,*p*′-DDE exposure occurs primarily through contamination via the food chain. Because of the persistence of *p*,*p*′-DDE in the body, past occupational exposure to DDT can also be relevant. Biologic measurement of DDE levels in the general population has demonstrated higher levels among African Americans compared with whites \[[@b6-ehp0112-001080]\] and higher levels among people born in the southern and western regions of the United States compared with other regions ([@b15-ehp0112-001080]). Reasons for these differences have not been established but could include differing exposure experience with respect to farming and diet.

We used data from a population of African-American farmers from North Carolina to examine the association between *p*,*p*′-DDE levels and immunologic parameters. Because of the historical use of DDT on cotton, tobacco, and other crops grown in this region, we anticipated that exposure levels in this study population would be higher than in general population samples. The immunologic measures we used were serum levels of immunoglobulin A (IgA) and IgG, as measures of mucosal and humoral immune responses. A previous study of residents living around a dump site had reported a positive association between DDE and IgA but no association between DDE and IgG ([@b36-ehp0112-001080]). We measured antinuclear antibodies to assess the potential effect on autoimmunity. Antinuclear antibodies may occur after infections and with some chronic diseases, particularly among the elderly ([@b16-ehp0112-001080]), but high-titer levels of antinuclear antibodies are a distinctive feature of the autoimmune disease systemic lupus erythematosus. The potential androgen-agonist properties of *p*,*p*′-DDE ([@b17-ehp0112-001080]) can be hypothesized to increase the risk of this disease ([@b8-ehp0112-001080]).

Materials and Methods
=====================

Study design.
-------------

The Agricultural Health Study is a prospective study of licensed pesticide applicators from Iowa and North Carolina ([@b1-ehp0112-001080]). Recruitment took place at the time of licensure or renewal, with enrollment of approximately 52,000 applicators (farmers and commercial applicators) and 32,000 spouses between 1994 and 1997. Because only a small percentage (2.5%) of applicators were African American, a separate recruitment effort was undertaken to identify additional African-American farmers who did not currently hold a pesticide applicator's license but who may have previously applied pesticides. This add-on study was designed to look at DDE and androgens in men ([@b21-ehp0112-001080]). Because men were more likely than women to have been engaged in farming activities including pesticide application, it was anticipated that their levels of DDE would be higher, making it easier to detect any associations with immunologic parameters.

Farmers and retired farmers were recruited through 118 predominantly black churches in five rural North Carolina counties (Warren, Halifax, Northampton, Bertie, and Sampson) in 1995 and 1996. This analysis is based on the sample of African-American male farmers or farmworkers ≥ 18 years of age who lived in one of these counties, had at least 2 years of farmwork experience as an adult, and completed a follow-up telephone interview that included more detailed questions on previous farming, pesticide use, and DDT. Details of the recruitment and data collection procedures for this sample have been previously described ([@b21-ehp0112-001080]). Of the 334 men who were eligible for the telephone follow-up study, 275 (82%) completed this portion of the study. Blood sample collection was limited to participants from four adjacent counties (Warren, Halifax, Northampton, and Bertie counties) because of distance and budgetary constraints. Of the 228 men who were eligible for the blood draw, 30 were excluded because of medical conditions such as use of anticoagulant medications or high blood pressure that precluded blood collection. Blood samples were collected from 138 (70%) of 198 eligible persons. The final sample (*n* = 137) excluded 1 participant who was found to have a plasma *p*,*p*′-DDE concentration of 232 μg/L, three times higher than the maximum value among all other samples. The study protocol was approved by the institutional review boards at the National Institute for Environmental Health Sciences and the University of Michigan.

Total years of pesticide use were obtained in the follow-up telephone interview. Additional data collected in this follow-up interview included age at time of blood draw, education level, total years smoked, alcohol consumption in the last 12 months, physical activity on current or last job, and physical activity for recreation. Height and weight were measured using a standard protocol before blood was drawn and were used to calculate body mass index (kilograms per square meter). History of immune-mediated diseases and other medical conditions was obtained in the enrollment and telephone interviews. None of the participants in this study reported a history of leukemia, Hodgkin disease, non-Hodgkin lymphoma, or lupus.

Fasting blood samples were drawn before 1100 hr. Plasma was separated from the whole-blood sample on the day of the blood draw, and aliquots were frozen at −20°C. Serum samples were obtained from a separate tube of blood immediately after clotting. Aliquots (1 mL) of serum were refrigerated at 4°C until delivery within 48 hr of collection to the Duke University CARL Clinical Laboratory (Durham, NC) for immediate analysis of lipids.

Laboratory analyses.
--------------------

DDE was extracted from 2 mL of plasma using solid-phase extraction (C~18~) by the Centre de Toxicologie du Québec (Sainte-Foy, Québec, Canada). After a washing step, *p*,*p*′-DDE was eluted with isooctane. The extract was then analyzed by gas chromatography with electron capture detection. Identification and quantification of DDE were confirmed by mass spectrometry. ^13^C-labeled *p*,*p*′-DDE was used as an internal standard. The limits of quantification and detection for total *p*,*p*′-DDE were 0.5 μg/L and 0.2 μg/L, respectively. All study samples were above the detection limit for *p*,*p*′-DDE. For purposes of quality control, a 5 μg/L *p*,*p*′-DDE standard and a 25 μg/L *p*,*p*′-DDE standard were analyzed with each batch. The between-batch coefficient of variation for the standards was 5.2% and 8.3%, respectively, and recovery averaged 97%.

Total cholesterol was quantified using a cholesterol oxidase/cholesterol esterase fully enzymatic procedure using the Hitachi 911 Automatic Chemistry Analyzer (Roche Diagnostic Corporation, Indianapolis, IN). Triglycerides were determined enzymatically with a glycerol phosphate oxidase/peroxidase system after blanking for endogenous free glycerol concentration (before hydrolysis of the triglycerides by lipase). All study samples were within the reportable ranges of 3--800 mg/dL for total cholesterol and 4--1,000 mg/dL for triglycerides. The mean within-batch coefficient of variation was 0.61% for total cholesterol and 1.02% for triglycerides.

Serum was analyzed for total IgG and IgA using a sandwich ELISA assay. Polyclonal affinity-purified goat anti-human IgG or IgA (ICN Biomedicals, Inc., Aurora, OH) was bound to a solid phase using Immulon 1 plates (Dynex Technologies, Chantilly, VA) at a concentration of 150 μg in 150 μL phosphate-buffered saline (PBS). Excess antibody was removed by washing, and nonspecific binding was blocked by incubation with PBS/0.05% Tween 20 containing 0.5% bovine serum albumin. Test serum (200 μL) was then added to each well. After a 2-hr incubation, the plates were washed and the bound immunoglobulins were labeled with 150 μg peroxidase-conjugated goat anti-human IgG/IgA/IgM antibody (ICN Biomedicals, Inc.). Unbound antibody was removed by repeated washing, and immunoglobulins were detected using the horseradish peroxidase substrate kit (Bio-Rad, Hercules, CA) according to the manufacturer's instructions.

Serum antinuclear antibodies specific to Sm, double-stranded DNA, SSA/Ro, SSB/La, histone, RNP, Scl-70, Jo-1, and centromeric antigens were analyzed using Hep-2 nucleus antigens with the BINDAZYME ANA (antinuclear antibody) EIA Kit (The Binding Site, Birmingham, UK). Antinuclear antibodies were detected with peroxidase-labeled anti-human IgG conjugate and 3,3′,5,5′ tetramethylbenzidine. Positive, cutoff, and negative controls were included on each plate. The ANA result for each sample was calculated as the ratio of the test sample to the cutoff control (optical density of test sample/optical density of cutoff control). An antinuclear antibody score of ≥ 1.0 was interpreted as positive, as suggested by the manufacturer. The scores for positive individuals ranged from 1.13 to 4.70. Four known positive sera (samples from patients with systemic lupus erythematosus) and four known negative sera were included in the assays in a blind fashion. All known positive samples tested positive for antinuclear antibodies, and all known negative samples tested negative.

Statistical analysis.
---------------------

We used linear regression models of IgA and IgG levels to examine the association with plasma levels of *p*,*p*′-DDE adjusting for age, cholesterol, and triglycerides as continuous variables, and smoking status (current smoker, non-current smoker). We also adjusted for total years of pesticide use of any kind in these models. The log~e~ transformation of IgA and IgG variables was used to decrease the variance heterogeneity. The exponential of the β-coefficients from a linear regression using these transformed variables can be taken as an estimate of the percent change in IgA or IgG associated with the corresponding change in DDE. In addition, dichotomous variables were created to represent values of IgA and IgG above the 75th percentile cut points of the distributions (cut points are shown in [Tables 1](#t1-ehp0112-001080){ref-type="table"} and [2](#t2-ehp0112-001080){ref-type="table"}); we used logistic regression to examine the relation between *p*,*p*′-DDE and these dependent variables. Logistic regression was also used with prevalence of antinuclear antibodies as the outcome. The relation of outcome to *p*,*p*′-DDE was evaluated using the four categories of exposure (\< 3, 3. 0--5.9, 6.0--11.9, and ≥ 12.0 μg/L) with indicator variables for the highest three groups, and by using three types of trend test: one with *p*,*p*′-DDE category as an ordinal variable, one with subjects in a given *p*,*p*′-DDE category assigned to the median exposure level for that category, and one with *p*,*p*′-DDE level as a continuous variable.

Results
=======

The median age of the study participants was 64 years, and age ranged from 30 to 88 years ([Table 1](#t1-ehp0112-001080){ref-type="table"}). Nine percent were current smokers. The median number of years smoked among the 81 ever-smokers was 12 years. Most participants (87%) were no longer working on a farm, but the mean number (± SD) of years farmed was 29.6 ± 16.7. The mean IgA level was 222.5 mg/dL, and the mean IgG was 1,665 mg/dL. Sixteen (12%) were classified as positive for antinuclear antibodies. The median plasma *p*,*p*′-DDE concentration was 7.7 μg/L (range, 0.6--77.4 μg/L).

We found no association between IgA and *p*,*p*′-DDE in any of the models ([Table 2](#t2-ehp0112-001080){ref-type="table"}). IgG levels, however, generally decreased with increasing *p*,*p*′-DDE levels. The association appears to be nonlinear such that the statistically significant differences (\~ 50% decrease in IgG) were seen in the higher two categories of exposure and with the ordinal trend test but not with the analysis using median values per group in the trend test or using DDE as a continuous variable. The prevalence of antinuclear antibodies was elevated in the highest category of *p*,*p*′-DDE exposure (odds ratio, 1.9; 95% confidence interval, 0.32--11.3), but this association was not statistically significant within this group or in the trend tests across the four levels of exposure. We found no association between years of any kind of pesticide use and IgG or prevalence of antinuclear antibodies (data not shown), but there was some evidence that IgA was positively associated with years of pesticide use (ordinal trend test *p*-value = 0.03 in the analysis using log-transformed IgA as the dependent variable). Although adjusting for overall years of pesticide use could theoretically have attenuated any association between DDE and IgA levels if DDE levels were associated with years of pesticide use, we did not see an association with IgA even when overall years of use was excluded from the models.

Discussion
==========

In this study of African-American farmers from the southeastern United States, we observed an inverse association between levels of *p*,*p*′-DDE and IgG. We found no significant association between the concentration of *p*,*p*′-DDE and IgA, the immunoglobulin class that is primarily responsible for protecting mucosal surfaces (e.g., the respiratory and gastrointestinal tract). Few other studies have focused on immunologic parameters and DDE or DDT exposure in humans. In contrast to our findings, [@b36-ehp0112-001080] reported an increase in total lymphocytes and higher IgA levels, but not IgG levels, in relation to increasing *p*,*p*′-DDE levels in a study of 302 adults residing around a pesticide dump site in North Carolina. In that study, exposure levels were lower (DDE median, 2 μg/L) compared with our study population (median, 7.7 μg/L). In the general population, the main source of *p*,*p*′-DDE is diet ([@b12-ehp0112-001080]), and diet undoubtedly contributed to exposure among the subjects in the present study of African-American farmers. In addition, subjects in our study who had used DDT on crops in the past had slightly higher serum *p*,*p*′-DDE levels (data not shown). Although DDT was banned in 1972, the half-life is relatively long (\> 5 years), and previous use likely accounts for the elevated levels in our subjects ([@b37-ehp0112-001080]). DDE is stored more tenaciously in humans than is DDT, and *p*,*p*′-DDE levels increase in plasma after DDT intake has decreased ([@b32-ehp0112-001080]). Besides diet, additional exposure in both our study and the study by [@b36-ehp0112-001080] was through contaminated air; thus, the expected routes of inhalation and/or dermal absorption were similar. We do not know how differences in dose or other study characteristics contributed to the associations with different types of immunoglobulins observed in these two studies.

Higher levels of prenatal *p*,*p*′-DDE were associated with an increased incidence of otitis media in a study of 171 Inuit infants ([@b9-ehp0112-001080]). Studies of individuals occupationally exposed to DDT also suggest that long-term exposure may lead to altered resistance to infectious diseases. [@b14-ehp0112-001080] found a higher prevalence of infectious diseases in workers who had directly worked with DDT and lindane for 12--30 years compared with a control population of 1,000 individuals. Upper respiratory tract infections such as tonsillitis, bronchitis, and pharyngitis were the most frequently observed. These investigators also found deficits in neutrophil function, including decreased chemotaxis, phagocytic activity, and respiratory burst ([@b14-ehp0112-001080]). Similar associations between increased infectious disease and pesticide exposure were later reported for a larger cohort ([@b13-ehp0112-001080]); however, there were no significant differences in neutrophil function in the larger study.

The function of immunoglobulin is to inactivate or eliminate pathogenic organisms, and individuals with severely reduced levels of serum IgG due to primary immunodeficiencies suffer from recurring infections ([@b31-ehp0112-001080]). However, the clinical significance of modestly reduced serum IgG or IgG subclass levels remains controversial and is evidenced by the identification of asymptomatic individuals with abnormally low serum IgG subclass concentrations who do not have increased rates of infectious disease ([@b20-ehp0112-001080]). At 4--6 months of age, neonates lose the protection of maternally derived IgGs, and at 7--12 months of age, IgG and IgM levels are approximately 50% of adult levels ([@b33-ehp0112-001080]). Infants of this age have been shown to be particularly susceptible to infections with encapsulated bacterial pathogens associated with upper respiratory tract infections. In the studies described above, the observed decrease in serum IgG levels with increasing *p*,*p*′-DDE suggests the potential for increased susceptibility to pathogens whose clearance is IgG mediated, such as *Haemophilus influenzae* and *Streptococcus pneumoniae* ([@b20-ehp0112-001080]). Our study was designed to examine immunologic parameters rather than clinical end points, but some medical history data were collected as part of the screening and enrollment process. Seventeen (12%) of the study participants reported a history of pneumonia. This prevalence did not vary by DDE level (14, 21, 10, and 15% in the lowest to highest DDE group, respectively). A larger study focusing on specific infectious diseases (and including validated medical history data) would be needed to examine the association between DDE and clinical outcomes.

Several studies have examined the relation between use of specific pesticides and presence of autoantibodies with inconsistent results ([@b7-ehp0112-001080]; [@b22-ehp0112-001080], [@b23-ehp0112-001080]; [@b29-ehp0112-001080]; [@b34-ehp0112-001080]). In the largest study of this type, self-reported use of some organochlorine pesticides (aldrin, chlordane, dieldrin, endrin, heptachlor, and lindane) was associated with increased prevalence of low-titer (1:40) antinuclear antibodies in a farming community ([@b29-ehp0112-001080]). The authors noted that the association with diphenyl chlorines (DDT and methoxychlors) was not statistically significant, but data pertaining to the prevalence of this exposure and the magnitude and precision of the observed association were not given. Although we observed the highest prevalence of antinuclear antibodies in the highest category of *p*,*p*′-DDE exposure in our study, this association was not statistically significant. Larger and expanded studies that are able to identify and quantify specific autoantibody levels are needed to more clearly examine this relationship.

Study participants were ambulatory members of the community, recruited through churches rather than through a hospital or clinic setting. When we excluded the six individuals who reported a history of kidney failure or dialysis or cancer, the results pertaining to the association between DDE and IgG levels were essentially unchanged (data not shown). Based on these self-reported data pertaining to medical conditions, we believe that major illnesses (cancer, malnutrition) were unlikely to be influencing the IgG levels seen in this study population.

A strength of this study is that the levels of *p*,*p*′-DDE observed in study participants were higher than those reported by [@b36-ehp0112-001080] in community residents and higher than in the general population ([@b6-ehp0112-001080]). This difference in exposure level may reflect the influence of occupational exposure through farmwork, in addition to background exposure from the food supply and other environmental sources. This variability in exposure improves our ability to detect an effect of *p*,*p*′-DDE that occurs with higher exposures, such as those that may occur in occupationally exposed populations. Although our study sample size was modest, our failure to confirm the association between *p*,*p*′-DDE and IgA observed previously by [@b36-ehp0112-001080] is unlikely to be due to limited statistical power because we saw no evidence of a trend that would have been strengthened with greater precision.

The reduced IgG levels seen with increasing *p*,*p*′-DDE provides evidence of potential immunosuppression associated with this exposure. These findings are consistent with data from experimental studies in rats and mice ([@b3-ehp0112-001080], [@b4-ehp0112-001080]; [@b5-ehp0112-001080]; [@b10-ehp0112-001080]; [@b27-ehp0112-001080]) and with an *in vitro* study reporting decreased macrophage activation with DDT/DDE exposure ([@b25-ehp0112-001080]). Thus, in addition to potential effects on reproductive outcomes, including preterm birth ([@b18-ehp0112-001080]) and impaired lactation ([@b11-ehp0112-001080]; [@b28-ehp0112-001080]), immune-mediated health effects such as infectious diseases and autoimmune diseases should be considered when evaluating the long-term consequences of DDT use.

Figures and Tables
==================

###### 

Characteristics of 137 African-American farmers in North Carolina, 1999.

                                                                                              No. (%)   Mean ± SD       Median
  ------------------------------------------------------------------------------------------- --------- --------------- --------
  Age                                                                                                   61.7 ± 13.1     63.7
  Education                                                                                                             
   Less than high school                                                                      67 (49)                   
   Completed high school                                                                      40 (29)                   
   More than high school                                                                      30 (22)                   
  Body mass index (kg/m^2^)                                                                             28.7 ± 4.7      28.1
  Smoking status                                                                                                        
   Never                                                                                      56 (41)                   
   Former                                                                                     68 (50)                   
   Current                                                                                    13 (9)                    
  Years of pesticide use                                                                                12.3 ± 13.4     8.0
  Years of DDT use                                                                                      2.2 ± 5.5       0.0
  DDE (μg/L)                                                                                            11.4 ± 12.2     7.7
  Cholesterol (mg/dL)                                                                                   208.29 ± 35.1   206.0
  Triglycerides (mg/dL)                                                                                 127.7 ± 84.1    103.0
  IgA (mg/dL)[*^a^*](#tfn1-ehp0112-001080){ref-type="table-fn"}                                         222.5 ± 313.4   96.7
  IgG (mg/dL)                                                                                           1,665 ± 1,761   1,170
  Positive antinuclear antibodies (≥ 1.0)[*^b^*](#tfn2-ehp0112-001080){ref-type="table-fn"}   16 (12)                   

One missing value.

Ratio of optical density of test sample to optical density of cutoff control sample.

###### 

Regression analyses of *p*,*p*′-DDE in relation to immunologic measures among African-American farmers in North Carolina, 1999.[*^a^*](#tfn4-ehp0112-001080){ref-type="table-fn"}

  Exposure measure                                                                   Linear regression   Logistic regression                                                                               
  ---------------------------------------------------------------------------------- ------------------- --------------------- ---------------- ------ ----------------------------------------- --------- -------------------
  \< 3.0                                                                             28                  Log-transformed IgA   Referent                Highest quartile IgA (≥ 251.5 mg/dL)      6 (21)    1.0 (referent)
  3.0--5.9                                                                           28                                        −0.113 (0.324)   0.73                                             4 (14)    0.53 (0.12--2.3)
  6.0--11.9                                                                          39                                        0.308 (0.305)    0.32                                             13 (33)   1.8 (0.54--5.9)
  ≥ 12.0                                                                             41                                        0.043 (0.318)    0.89                                             11 (27)   1.2 (0.34--4.3)
   Ordinal trend *p*-value[*^c^*](#tfn6-ehp0112-001080){ref-type="table-fn"}                                                                    0.59                                                       0.38
   Median-value trend *p*-value[*^d^*](#tfn7-ehp0112-001080){ref-type="table-fn"}                                                               0.82                                                       0.51
   Continuous: per unit increase                                                                                               −0.003 (0.009)   0.72                                             34 (25)   1.00 (0.97--1.04)
  \< 3.0                                                                             29                  Log-transformed IgG   Referent                Highest quartile IgG (≥ 2,110 mg/dL)      11 (38)   1.0 (referent)
  3.0--5.9                                                                           28                                        −0.463 (0.294)   0.12                                             10 (36)   0.89 (0.27--2.9)
  6.0--11.9                                                                          39                                        −0.717 (0.276)   0.01                                             8 (21)    0.34 (0.10--1.1)
  ≥ 12.0                                                                             41                                        −0.609 (0.289)   0.04                                             7 (17)    0.36 (0.10--1.3)
   Ordinal trend *p*-value[*^c^*](#tfn6-ehp0112-001080){ref-type="table-fn"}                                                                    0.03                                                       0.05
   Median-value trend *p*-value[*^d^*](#tfn7-ehp0112-001080){ref-type="table-fn"}                                                               0.13                                                       0.10
   Continuous: per unit increase                                                                                               −0.005 (0.008)   0.57                                             36 (26)   0.99 (0.95--1.05)
  \< 3.0                                                                             29                                                                Positive antinuclear antibodies (≥ 1.0)   2 (7)     1.0 (referent)
  3.0--5.9                                                                           28                                                                                                          2 (7)     0.75 (0.09--6.1)
  6.0--11.9                                                                          39                                                                                                          4 (10)    1.1 (0.17--7.2)
  ≥ 12.0                                                                             41                                                                                                          8 (20)    1.9 (0.32--11.3)
   Ordinal trend *p*-value[*^c^*](#tfn6-ehp0112-001080){ref-type="table-fn"}                                                                                                                               0.33
   Median-value trend *p*-value[*^d^*](#tfn7-ehp0112-001080){ref-type="table-fn"}                                                                                                                          0.25
   Continuous: per unit increase[*^e^*](#tfn8-ehp0112-001080){ref-type="table-fn"}                                                                                                               16 (12)   1.01 (0.97--1.05)

CI, confidence interval.

Adjusted for age, smoking status, total years of pesticide exposure (quartiles), cholesterol, and triglycerides; one value was missing for IgA, for a total number of 136 for IgA analyses and 137 for IgG and antinuclear antibody analyses.

"Positive" denotes those within each DDE group that are in the highest quartile of IgA, highest quartile of IgG, or "positive" for antinuclear antibodies, respectively.

Trend test using values of 1, 2, 3, and 4, respectively.

Trend test using median value per group.

Ratio of optical density of test sample to optical density of cutoff control sample.
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